Science
LambdaVision to Study Light-Activated Proteins on NASA’s Upcoming Flight to International Space Station – Business Wire
LambdaVision, an innovative biotech developing a treatment to help patients regain sight, will launch their artificial retina technology with engineer
FARMINGTON, Conn.–(BUSINESS WIRE)–LambdaVision, an innovative biotech developing a treatment to help patients regain sight, will launch their artificial retina technology with engineering partner Space Tango on Northrop Grummans 14th Commercial Resupply Services Mission for NASA (NG-14) to the International Space Station (ISS) U.S. National Laboratory. Scheduled to launch on September 30th at 2:26 UTC (10:26 p.m. ET), NG-14 is the first of a series of NASA flights to the ISS in low-Earth orbit…
-
Noosa News23 hours agoBasic cyber steps can block most attacks – Proctor
-
Noosa News18 hours agoWhat instrument did Japan’s heavy-metal PM play? Take the Brisbane Times Quiz
-
Noosa News21 hours agoCompetition watchdog approves Elders’ $475m acquisition of agribusiness rival Delta
-
Noosa News21 hours agoFamily ‘quite nasty’ to woman who married step-uncle before his alleged murder, court hears